Treatment group:Immunotherapy

5 trials

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Tianjin First Central Hospital, Gastrointestinal surgery,Fujian Provincial Cancer Hospital, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Conditions

Hepatocellular carcinomaextensive stage small cell lung cancerpituitary adenomatumor recurrence of hepatic malignancies after liver transplantation

Phase 2

Exploratory study of Transarterial Chemoembolization (TACE) combined with immunotherapy in the treatment of middle or advanced Stage hepatocellular Carcinoma(HCC)

Active, not recruitingChiCTR-OPC-15006703

Gastrointestinal surgery,Fujian Provincial Cancer HospitalHepatocellular carcinoma

Start: 2016-12-01Updated: 2017-04-18

Unknown Phase

Research of immunotherapy to prevent tumor recurrence of hepatic malignancies after liver transplantation

Active, not recruitingChiCTR-PNRC-12002354

Tianjin First Central Hospitaltumor recurrence of hepatic malignancies after liver transplantation

Start: 2010-01-01Updated: 2017-04-18

Clinical application of immunotherapy to prevent tumor recurrence of hepatic malignancies after liver transplantation

Active, not recruitingChiCTR-ONC-12002339

Tianjin First Central Hospitaltumor recurrence of hepatic malignancies after liver transplantation

Start: 2010-01-01Updated: 2017-04-18

Application of molecular targeted therapy assisted endoscopic surgery in the treatment of invasive pituitary adenomas

RecruitingChiCTR-OPN-16008964

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Collegepituitary adenoma

Start: 2013-01-01Updated: 2017-04-18

A randomized controlled clinical study of Yi Shen Gu Kang Fang Formula (Yi Shen Qu Tong Granules) in the treatment of small cell lung cancer

RecruitingChiCTR2400088796

Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical Collegeextensive stage small cell lung cancer

Start: 2024-04-20Updated: 2024-09-02